ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,536, issued on Feb. 17, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).
"Semaglutide in medical therapy" was invented by Maria Kabisch (Koebenhavn S, Denmark) and Thomas Hansen (Broenshoej, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to semaglutide for use in weight management."
The patent was filed on April 9, 2025, under Application No. 19/174,121.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12551536&OS=12551536&RS=12551536
Dis...